Jeongbeob Seo

This inventor holds 30 USPTO granted patents and 8 published patent applications, plus 3 CIPO patents and 12 EPO patents, primarily in Trk Kinase Inhibitors. Top assignees: Array Biopharma Inc., Genentech, Inc., Astrazeneca Ab. Active years: 2009-2020.

USPTO Granted Patents = 30 (Patent Applications = 8)

% Patents Active = 60.0

CIPO Patents = 3

EPO Patents = 12 (Patent Applications = 11)

Average Co-Inventor Count = 7.6

ph-index = 11

Forward Citations = 444(Granted Patents)

Location History:

Broomfield, CO (US) (2009 - 2017)
Baltimore, MD (US) (2015 - 2019)
Boulder, CO (US) (2012 - 2020)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2009-2020

Loading Chart...

Areas of Expertise:

Trk Kinase Inhibitors

MEK Inhibitors

Macrocyclic Compounds

Pyrimidine Compounds

Heterocyclic Compounds

Pyrrolidinyl Urea

Dihydropyridine Derivatives

Thiourea Compounds

Pyridazine Inhibitors

Heterobicyclic Thiophene

Pyrazole Compounds

Crystalline Forms

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10758542 - Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitors (2020-09-01),

2. 10647730 - Macrocyclic compounds as TRK kinase inhibitors (2020-05-12),

3. 10323022 - Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors (2019-06-18),

4. 10251889 - Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors (2019-04-09),

5. 9902741 - Macrocyclic compounds as TRK kinase inhibitors (2018-02-27),

6. 9878997 - Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors (2018-01-30),

7. 9840519 - Macrocyclic compounds as TRK kinase inhibitors (2017-12-12),

8. 9796724 - Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors (2017-10-24),

9. 9782415 - Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors (2017-10-10),

10. 9750744 - Macrocyclic compounds as Trk kinase inhibitors (2017-09-05),

11. 9718822 - Macrocyclic compounds as Trk kinase inhibitors (2017-08-01),

12. 9682979 - Substituted pyrazolo [1,5-A] pyrimidine compounds as TRK kinase inhibitors (2017-06-20),

13. 9562055 - Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors (2017-02-07),

14. 9493476 - Macrocyclic compounds as trk kinase inhibitors (2016-11-15),

15. 8933084 - Macrocyclic compounds as Trk kinase inhibitors (2015-01-13),

Title: Jeongbeob Seo: Pioneering Inventor from Boulder

Introduction: Jeongbeob Seo is a renowned inventor based in Boulder, CO, known for his groundbreaking innovations in various fields.

Latest Patents: Jeongbeob Seo's latest patents include advancements in renewable energy technologies, medical devices, and artificial intelligence systems.

Career Highlights: With a career spanning over two decades, Seo has been instrumental in developing cutting-edge solutions that have significantly impacted industries worldwide.

Collaborations: Throughout his career, Jeongbeob Seo has collaborated with leading research institutions, universities, and multinational companies to bring his inventions to life.

Conclusion: Jeongbeob Seo's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs.